UniProt ID | ANKZ1_HUMAN | |
---|---|---|
UniProt AC | Q9H8Y5 | |
Protein Name | Ankyrin repeat and zinc finger domain-containing protein 1 | |
Gene Name | ANKZF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 726 | |
Subcellular Localization | Cytoplasm . Translocates to the mitochondria upon exposure to hydrogen peroxide. | |
Protein Description | Plays a role in the cellular response to hydrogen peroxide and in the maintenance of mitochondrial integrity under conditions of cellular stress. [PubMed: 28302725 Involved in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway (By similarity] | |
Protein Sequence | MSPAPDAAPAPASISLFDLSADAPVFQGLSLVSHAPGEALARAPRTSCSGSGERESPERKLLQGPMDISEKLFCSTCDQTFQNHQEQREHYKLDWHRFNLKQRLKDKPLLSALDFEKQSSTGDLSSISGSEDSDSASEEDLQTLDRERATFEKLSRPPGFYPHRVLFQNAQGQFLYAYRCVLGPHQDPPEEAELLLQNLQSRGPRDCVVLMAAAGHFAGAIFQGREVVTHKTFHRYTVRAKRGTAQGLRDARGGPSHSAGANLRRYNEATLYKDVRDLLAGPSWAKALEEAGTILLRAPRSGRSLFFGGKGAPLQRGDPRLWDIPLATRRPTFQELQRVLHKLTTLHVYEEDPREAVRLHSPQTHWKTVREERKKPTEEEIRKICRDEKEALGQNEESPKQGSGSEGEDGFQVELELVELTVGTLDLCESEVLPKRRRRKRNKKEKSRDQEAGAHRTLLQQTQEEEPSTQSSQAVAAPLGPLLDEAKAPGQPELWNALLAACRAGDVGVLKLQLAPSPADPRVLSLLSAPLGSGGFTLLHAAAAAGRGSVVRLLLEAGADPTVQDSRARPPYTVAADKSTRNEFRRFMEKNPDAYDYNKAQVPGPLTPEMEARQATRKREQKAARRQREEQQQRQQEQEEREREEQRRFAALSDREKRALAAERRLAAQLGAPTSPIPDSAIVNTRRCWSCGASLQGLTPFHYLDFSFCSTRCLQDHRRQAGRPSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSPAPDAAP ------CCCCCCCCC | 29.75 | 25159151 | |
15 | Phosphorylation | APAPASISLFDLSAD CCCCCEEEEEECCCC | 22.08 | 46164489 | |
46 | Phosphorylation | ALARAPRTSCSGSGE HHHCCCCCCCCCCCC | 32.78 | 68705089 | |
47 | Phosphorylation | LARAPRTSCSGSGER HHCCCCCCCCCCCCC | 13.94 | 28985074 | |
49 | Phosphorylation | RAPRTSCSGSGERES CCCCCCCCCCCCCCC | 35.44 | 68705101 | |
51 | Phosphorylation | PRTSCSGSGERESPE CCCCCCCCCCCCCHH | 22.61 | 30576142 | |
56 | Phosphorylation | SGSGERESPERKLLQ CCCCCCCCHHHHHHC | 37.98 | 25159151 | |
66 | Sulfoxidation | RKLLQGPMDISEKLF HHHHCCCCCHHHHHH | 10.26 | 21406390 | |
75 | Phosphorylation | ISEKLFCSTCDQTFQ HHHHHHCCCCHHHHH | 25.41 | 28555341 | |
80 | Phosphorylation | FCSTCDQTFQNHQEQ HCCCCHHHHHHHHHH | 17.59 | 28555341 | |
101 | Methylation | DWHRFNLKQRLKDKP CHHHCCHHHHHCCCC | 34.18 | - | |
119 | Phosphorylation | ALDFEKQSSTGDLSS HHCHHCCCCCCCHHH | 40.72 | 17081983 | |
120 | Phosphorylation | LDFEKQSSTGDLSSI HCHHCCCCCCCHHHC | 33.64 | 17081983 | |
121 | Phosphorylation | DFEKQSSTGDLSSIS CHHCCCCCCCHHHCC | 39.71 | 17081983 | |
125 | Phosphorylation | QSSTGDLSSISGSED CCCCCCHHHCCCCCC | 30.30 | 22817900 | |
126 | Phosphorylation | SSTGDLSSISGSEDS CCCCCHHHCCCCCCC | 28.24 | 22817900 | |
128 | Phosphorylation | TGDLSSISGSEDSDS CCCHHHCCCCCCCCC | 37.91 | 22817900 | |
130 | Phosphorylation | DLSSISGSEDSDSAS CHHHCCCCCCCCCCC | 31.29 | 22817900 | |
133 | Phosphorylation | SISGSEDSDSASEED HCCCCCCCCCCCHHH | 29.43 | 22817900 | |
135 | Phosphorylation | SGSEDSDSASEEDLQ CCCCCCCCCCHHHHH | 37.33 | 22817900 | |
137 | Phosphorylation | SEDSDSASEEDLQTL CCCCCCCCHHHHHHH | 45.53 | 24461736 | |
155 | Phosphorylation | RATFEKLSRPPGFYP HHHHHHHCCCCCCCC | 54.53 | 28555341 | |
176 | Phosphorylation | NAQGQFLYAYRCVLG CCCCCEEEEEEHHHC | 11.68 | 83339 | |
242 | Methylation | RYTVRAKRGTAQGLR EEEEECCCCCCCCCC | 46.86 | - | |
252 | Methylation | AQGLRDARGGPSHSA CCCCCCCCCCCCCCC | 55.69 | - | |
256 | Phosphorylation | RDARGGPSHSAGANL CCCCCCCCCCCCCHH | 33.09 | 20068231 | |
258 | Phosphorylation | ARGGPSHSAGANLRR CCCCCCCCCCCHHHH | 32.51 | 25159151 | |
266 | Phosphorylation | AGANLRRYNEATLYK CCCHHHHCCHHHHHH | 15.77 | 22210691 | |
273 | Ubiquitination | YNEATLYKDVRDLLA CCHHHHHHHHHHHHC | 53.51 | - | |
286 | Ubiquitination | LAGPSWAKALEEAGT HCCHHHHHHHHHHCC | 47.44 | - | |
301 | O-linked_Glycosylation | ILLRAPRSGRSLFFG EEEECCCCCCCCCCC | 37.18 | 30379171 | |
310 | Ubiquitination | RSLFFGGKGAPLQRG CCCCCCCCCCCCCCC | 52.88 | - | |
310 | Acetylation | RSLFFGGKGAPLQRG CCCCCCCCCCCCCCC | 52.88 | 25953088 | |
361 | Phosphorylation | REAVRLHSPQTHWKT HHHHHCCCCCCHHHH | 24.24 | 22167270 | |
364 | Phosphorylation | VRLHSPQTHWKTVRE HHCCCCCCHHHHHHH | 32.84 | 30266825 | |
367 | Ubiquitination | HSPQTHWKTVREERK CCCCCHHHHHHHHHC | 29.54 | - | |
398 | Phosphorylation | ALGQNEESPKQGSGS HHCCCCCCCCCCCCC | 31.08 | 30266825 | |
462 | Phosphorylation | HRTLLQQTQEEEPST HHHHHHHHHCCCCCC | 25.61 | 28348404 | |
511 | Ubiquitination | AGDVGVLKLQLAPSP CCCCEEEEEEECCCC | 31.61 | - | |
517 | Phosphorylation | LKLQLAPSPADPRVL EEEEECCCCCCHHHH | 27.41 | 28674419 | |
525 | Phosphorylation | PADPRVLSLLSAPLG CCCHHHHHHHCCCCC | 25.14 | 24732914 | |
528 | Phosphorylation | PRVLSLLSAPLGSGG HHHHHHHCCCCCCCC | 32.88 | 24732914 | |
533 | Phosphorylation | LLSAPLGSGGFTLLH HHCCCCCCCCHHHHH | 43.35 | 29255136 | |
537 | Phosphorylation | PLGSGGFTLLHAAAA CCCCCCHHHHHHHHH | 31.52 | 29255136 | |
562 | Phosphorylation | LEAGADPTVQDSRAR HHCCCCCCCCCCCCC | 31.20 | 20068231 | |
566 | Phosphorylation | ADPTVQDSRARPPYT CCCCCCCCCCCCCCE | 15.68 | 20068231 | |
572 | Phosphorylation | DSRARPPYTVAADKS CCCCCCCCEEECCCH | 19.27 | 22817900 | |
573 | Phosphorylation | SRARPPYTVAADKST CCCCCCCEEECCCHH | 14.94 | 29083192 | |
579 | Phosphorylation | YTVAADKSTRNEFRR CEEECCCHHHHHHHH | 32.90 | 29083192 | |
580 | Phosphorylation | TVAADKSTRNEFRRF EEECCCHHHHHHHHH | 43.16 | 29083192 | |
599 | Methylation | PDAYDYNKAQVPGPL CCCCCCCCCCCCCCC | 33.69 | - | |
607 | Phosphorylation | AQVPGPLTPEMEARQ CCCCCCCCHHHHHHH | 21.97 | 29255136 | |
616 | Phosphorylation | EMEARQATRKREQKA HHHHHHHHHHHHHHH | 28.52 | 29514088 | |
653 | Phosphorylation | QRRFAALSDREKRAL HHHHHHHCHHHHHHH | 29.87 | 21815630 | |
674 | Phosphorylation | AAQLGAPTSPIPDSA HHHHCCCCCCCCCCC | 46.75 | 16964243 | |
675 | Phosphorylation | AQLGAPTSPIPDSAI HHHCCCCCCCCCCCE | 21.55 | 30175587 | |
680 | Phosphorylation | PTSPIPDSAIVNTRR CCCCCCCCCEECCCC | 17.97 | 27794612 | |
685 | Phosphorylation | PDSAIVNTRRCWSCG CCCCEECCCCCCCCC | 14.48 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ANKZ1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ANKZ1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANKZ1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TERA_HUMAN | VCP | physical | 21896481 | |
TERA_HUMAN | VCP | physical | 21914798 | |
A4_HUMAN | APP | physical | 21832049 | |
NAA35_HUMAN | NAA35 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398; THR-607 ANDSER-675, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-607 AND SER-675, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398 AND THR-607, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361, AND MASSSPECTROMETRY. |